Aileen Nicoletti is a vice president in the Life Sciences Practice at CRA. She has expertise in market research, new product planning, business development, and strategic planning. Dr. Nicoletti focuses on therapeutic area growth and portfolio management strategy for clinical stage pharmaceutical and biotech products. She has an understanding of key drivers from science and research, through clinical development, to the wants and needs of payer, patient, and physician stakeholders. Prior to her role at CRA, Dr. Nicoletti was a director at C1 Consulting and held various senior positions at Defined Health, including leading the Autoimmune and Inflammatory Disease and Ophthalmology Therapeutic Area.